Skip to main content

Table 1 Approved anticancer drugs using nanocarriersa

From: Advances in the field of nanooncology

Trade name/compound

Manufacturer

Nanocarrier

Abraxane/paclitaxel

Abraxis Biosciences

Albumin-bound paclitaxel

Bexxar/anti-CD20 conjugated to iodine-131

Corixa/GlaxoSmithKline

Radioimmunoconjugate

DaunoXome/daunorubicin

Diatos (available in France)

Liposome

Doxil/Caelyx/doxorubicin

Ortho Biotech

Liposome

Myoset/doxorubicin

Cephalon (available in Europe)

Nonpegylated liposome

Oncaspar/PEG-L-asparaginase

Enzon

Polymer-protein conjugate

Ontak/IL-2 fused to diphtheria toxin

Eisai Inc

Immunotoxic fusion protein

SMANCS/zinostatin

Yamanouchi Pharma

Polymer-protein conjugate

Zevalin/anti-CD20 conjugated to yttrium-90

Cell Therapeutics Inc.

Radioimmunoconjugate

Zoladex/goserelin acetate

AstraZeneca

Polymer rods

  1. aPEG, polyethylene glycol; IL-2, interleukin-2; SMANCS, styrene maleic anhydride neocarzinostatin. Reproduced by permission © Jain PharmaBiotech.